Incorporating Coexisting Chronic Illness into Decisions about Patient Selection for Lung Cancer Screening. An Official American Thoracic Society Research Statement
- 15 July 2018
- journal article
- research article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 198 (2), e3-e13
- https://doi.org/10.1164/rccm.201805-0986st
Abstract
Background: Lung cancer screening (LCS) has the potential to reduce the risk of lung cancer death in healthy individuals, but the impact of coexisting chronic illnesses on LCS outcomes has not been well defined. Consideration of the complex relationship between baseline risk of lung cancer, treatment-related harms, and risk of death from competing causes is crucial in determining the balance of benefits and harms of LCS. Objectives: To summarize evidence, identify knowledge and research gaps, prioritize topics, and propose methods for future research on how best to incorporate comorbidities in making decisions regarding LCS. Methods: A multidisciplinary group of international clinicians and researchers reviewed available data on the effects of comorbidities on LCS outcomes, focusing on the juxtaposition of lung cancer risk and competing risks of death, consideration of benefits and risks in patients with chronic obstructive pulmonary disease, communication of risk, and treatment of screen-detected lung cancer. Results: This statement identifies gaps in knowledge regarding how comorbidities and competing causes of death impact outcomes in LCS, and we have developed questions to help guide future research efforts to better inform patient selection, education, and implementation of LCS. Conclusions: There is an urgent need for further research that can help guide clinical decision-making with patients who may not benefit from LCS owing to coexisting chronic illness. This statement establishes a research framework to address essential questions regarding how to incorporate and communicate risks of comorbidities into patient selection and decisions regarding LCS.This publication has 51 references indexed in Scilit:
- American Cancer Society lung cancer screening guidelinesCA: A Cancer Journal for Clinicians, 2013
- Systematic Review of Comorbidity Indices for Administrative DataMedical Care, 2012
- Thoracoscopic Lobectomy Has Increasing Benefit in Patients With Poor Pulmonary FunctionAnnals of Surgery, 2012
- Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic ScreeningThe New England Journal of Medicine, 2011
- Baseline Characteristics of Participants in the Randomized National Lung Screening TrialJNCI Journal of the National Cancer Institute, 2010
- Pulmonary Function Tests Do Not Predict Pulmonary Complications After Thoracoscopic LobectomyThe Annals of Thoracic Surgery, 2010
- Survival of Patients with Stage I Lung Cancer Detected on CT ScreeningThe New England Journal of Medicine, 2006
- Impact of comorbidity on lung cancer survivalInternational Journal of Cancer, 2002
- The Influence of Hospital Volume on Survival after Resection for Lung CancerThe New England Journal of Medicine, 2001
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987